Aotearoa Clinical Trials logo

Latest News

Aotearoa Clinical Trials Expands to New Site in Botany, East Auckland, Strengthening Community Access to Clinical Trials

Aotearoa Clinical Trials Expands to New Site in Botany, East Auckland, Strengthening Community Access to Clinical Trials

10/02/2025

Aotearoa Clinical Trials is pleased to announce the opening of a new, third site in Botany, East Auckland, expanding its reach and further cementing its commitment to the local community. This new standalone site will allow the clinical trial organisation to provide enhanced access to a diverse range of participants, while strategically supporting the Counties Manukau region’s rapidly growing population.

Read more
Maternal RSV Vaccine Approved by FDA

Maternal RSV Vaccine Approved by FDA

27/10/2023

Aotearoa Clinical Trials is proud to have been part of the MATISSE Trial. ABRYSVO™, Pfizer’s bivalent RSV preF vaccine for the prevention of Lower Respiratory Tract Disease (LRTD) and severe LRTD caused by RSV in infants from birth up to six months of age was approved by the FDA on 21st August 2023.

Read more